跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml - HSA Drug Approval Details
Approvals
/
HSA
/
SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml
Approved
THERAPEUTIC
SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml
Amherst Laboratories, Inc
🇸🇬 Health Sciences Authority
Approval Date
Apr 3, 2003
Approval ID
94cc7761f75de40f
Company
Amherst Laboratories, Inc
Type
Therapeutic
Approval Details
Approval Id
94cc7761f75de40f
Drug Name
SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml
Product Name
SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml
Approval Number
SIN12251P
Approval Date
2003-04-03
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Pharmacy Only
Dosage Form
SUSPENSION
Route Of Administration
ORAL
Atc Code
R05CB03
Atc Item Name
carbocisteine
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
CARBOCISTEINE
200 mg/5 ml
CARBOCISTEINE
200 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 3, 2003
Approval ID
94cc7761f75de40f
Type
Therapeutic
Back to HSA Approvals